ReviewCellular & molecular immunology2026
Integrating host-microbiota metabolic networks: how aromatic amino acids shape immune homeostasis and affect disease progression.
Review in Cellular & molecular immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Epigenetics, bacterial metabolites and type 2 diabetes: a new view of gut-genome interactions.Frontiers in microbiology · 2026Review
- From gut microbiota dysbiosis to immune dysregulation: pathogenic mechanisms and emerging therapeutic perspectives in pediatric asthma.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Gut microbial metabolism is intimately linked to host immune homeostasis. Aromatic amino acids (AAAs) serve as substrates for both host and microbial enzymes, yielding a diverse array of metabolites that shape immune responses at local and systemic sites. In this review, an integrated framework is provided for understanding how AAA metabolites orchestrate immune cell function. The journey of AAAs from dietary intake through intestinal absorption and microbial utilization is traced, emphasizing the cooperative metabolic networks that generate immunomodulatory compounds. How these metabolites act on dendritic cells, macrophages, T cells, and B cells through membrane receptors, nuclear receptors, and epigenetic modifications to achieve cell‑type‑specific effects is subsequently examined. Drawing on recent discoveries, including cooperative microbial interactions in tryptophan metabolism, AAA metabolism is best understood as an integrated network rather than separate host and microbial compartments. How the dysregulation of these pathways contributes to inflammatory bowel disease and infectious diseases is further discussed, and emerging therapeutic strategies targeting the microbiota‑metabolite‑immune axis are highlighted. By synthesizing molecular mechanisms, cellular targets, and disease contexts, this review offers a conceptual roadmap for precision interventions that leverage the intricate metabolic connections between the host and microbiota.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.